HEADER ANTIBIOTIC 14-SEP-23 8U78 TITLE STRUCTURE OF A N-ME-D-GLN4,LYS10-TEIXOBACTIN ANALOGUE COMPND MOL_ID: 1; COMPND 2 MOLECULE: N-METHYL-D-GLN4,LYS10-TEIXOBACTIN; COMPND 3 CHAIN: A, B, C, D, E, F, G, H; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: ELEFTHERIA TERRAE; SOURCE 4 ORGANISM_TAXID: 1597781 KEYWDS ANTIBIOTIC, TEIXOBACTIN, TEIXOBACTIN ANALOGUE EXPDTA X-RAY DIFFRACTION AUTHOR J.S.NOWICK,H.YANG,A.G.KREUTZER REVDAT 3 17-APR-24 8U78 1 JRNL REVDAT 2 03-APR-24 8U78 1 JRNL REVDAT 1 06-MAR-24 8U78 0 JRNL AUTH H.YANG,A.G.KREUTZER,J.S.NOWICK JRNL TITL SUPRAMOLECULAR INTERACTIONS OF TEIXOBACTIN ANALOGUES IN THE JRNL TITL 2 CRYSTAL STATE. JRNL REF J.ORG.CHEM. V. 89 5104 2024 JRNL REFN ISSN 0022-3263 JRNL PMID 38506062 JRNL DOI 10.1021/ACS.JOC.3C02617 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.20.1_4487: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.88 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.400 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 10318 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.157 REMARK 3 R VALUE (WORKING SET) : 0.154 REMARK 3 FREE R VALUE : 0.183 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.980 REMARK 3 FREE R VALUE TEST SET COUNT : 1030 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 24.8800 - 2.8700 1.00 1341 148 0.1266 0.1491 REMARK 3 2 2.8700 - 2.2800 1.00 1309 156 0.1562 0.1621 REMARK 3 3 2.2800 - 1.9900 1.00 1336 142 0.1672 0.2001 REMARK 3 4 1.9900 - 1.8100 1.00 1337 143 0.1728 0.2248 REMARK 3 5 1.8100 - 1.6800 1.00 1293 146 0.1857 0.2553 REMARK 3 6 1.6800 - 1.5800 1.00 1339 147 0.1813 0.2437 REMARK 3 7 1.5800 - 1.5000 1.00 1333 148 0.2074 0.2578 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.140 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.710 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 14.35 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.014 713 REMARK 3 ANGLE : 2.013 944 REMARK 3 CHIRALITY : 0.098 128 REMARK 3 PLANARITY : 0.009 104 REMARK 3 DIHEDRAL : 31.778 122 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8U78 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-SEP-23. REMARK 100 THE DEPOSITION ID IS D_1000277364. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JUN-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.2.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99997 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : POINTLESS, AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10322 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 24.880 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.01774 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 24.0900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.19340 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.240 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: PHENIX HYSS, PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 25.27 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.65 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG3350, MGCL2, PH 6, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+3/4 REMARK 290 4555 Y,-X,Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.15750 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 79.73625 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 26.57875 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: OCTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE N-METHYL-D-GLN4,LYS10-TEIXOBACTIN IS PEPTIDE-LIKE, A MEMBER OF REMARK 400 ANTIBIOTIC CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: N-METHYL-D-GLN4,LYS10-TEIXOBACTIN REMARK 400 CHAIN: A REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 H10 HJV C 4 O HOH C 201 1.32 REMARK 500 O HOH B 202 O HOH B 204 1.83 REMARK 500 O HOH F 210 O HOH F 211 2.06 REMARK 500 NE2 HJV C 4 O HOH C 201 2.12 REMARK 500 NE2 HJV C 4 O HOH C 202 2.12 REMARK 500 O HOH E 209 O HOH F 202 2.13 REMARK 500 OG1 DTH G 8 O ILE G 11 2.18 REMARK 500 O HOH F 202 O HOH F 207 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH F 203 O HOH F 204 1565 1.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HJV E 4 -58.94 92.94 REMARK 500 HJV G 4 -61.61 110.57 REMARK 500 REMARK 500 REMARK: NULL DBREF 8U78 A 1 11 PDB 8U78 8U78 1 11 DBREF 8U78 B 1 11 PDB 8U78 8U78 1 11 DBREF 8U78 C 1 11 PDB 8U78 8U78 1 11 DBREF 8U78 D 1 11 PDB 8U78 8U78 1 11 DBREF 8U78 E 1 11 PDB 8U78 8U78 1 11 DBREF 8U78 F 1 11 PDB 8U78 8U78 1 11 DBREF 8U78 G 1 11 PDB 8U78 8U78 1 11 DBREF 8U78 H 1 11 PDB 8U78 8U78 1 11 SEQRES 1 A 11 ZAE ILE SER HJV 28J ILE SER DTH ALA LYS ILE SEQRES 1 B 11 ZAE ILE SER HJV 28J ILE SER DTH ALA LYS ILE SEQRES 1 C 11 ZAE ILE SER HJV 28J ILE SER DTH ALA LYS ILE SEQRES 1 D 11 ZAE ILE SER HJV 28J ILE SER DTH ALA LYS ILE SEQRES 1 E 11 ZAE ILE SER HJV 28J ILE SER DTH ALA LYS ILE SEQRES 1 F 11 ZAE ILE SER HJV 28J ILE SER DTH ALA LYS ILE SEQRES 1 G 11 ZAE ILE SER HJV 28J ILE SER DTH ALA LYS ILE SEQRES 1 H 11 ZAE ILE SER HJV 28J ILE SER DTH ALA LYS ILE HET ZAE A 1 25 HET HJV A 4 20 HET 28J A 5 18 HET DTH A 8 12 HET ZAE B 1 25 HET HJV B 4 20 HET 28J B 5 18 HET DTH B 8 12 HET ZAE C 1 25 HET HJV C 4 20 HET 28J C 5 18 HET DTH C 8 12 HET ZAE D 1 25 HET HJV D 4 20 HET 28J D 5 18 HET DTH D 8 12 HET ZAE E 1 25 HET HJV E 4 20 HET 28J E 5 18 HET DTH E 8 12 HET ZAE F 1 25 HET HJV F 4 20 HET 28J F 5 18 HET DTH F 8 12 HET ZAE G 1 25 HET HJV G 4 20 HET 28J G 5 18 HET DTH G 8 12 HET ZAE H 1 25 HET HJV H 4 20 HET 28J H 5 18 HET DTH H 8 12 HET CL A 101 1 HET CL A 102 1 HET CL A 103 1 HET CL B 101 1 HET CL B 102 1 HET CL C 101 1 HET CL C 102 1 HET CL D 101 1 HET CL D 102 1 HET CL E 101 1 HET CL E 102 1 HET CL F 101 1 HET CL G 101 1 HET PG6 G 102 44 HET CL H 101 1 HETNAM ZAE N-METHYL-D-PHENYLALANINE HETNAM HJV N~2~-METHYL-D-GLUTAMINE HETNAM 28J D-ALLOISOLEUCINE HETNAM DTH D-THREONINE HETNAM CL CHLORIDE ION HETNAM PG6 1-(2-METHOXY-ETHOXY)-2-{2-[2-(2-METHOXY-ETHOXY]- HETNAM 2 PG6 ETHOXY}-ETHANE FORMUL 1 ZAE 8(C10 H13 N O2) FORMUL 1 HJV 8(C6 H12 N2 O3) FORMUL 1 28J 8(C6 H13 N O2) FORMUL 1 DTH 8(C4 H9 N O3) FORMUL 9 CL 14(CL 1-) FORMUL 22 PG6 C12 H26 O6 FORMUL 24 HOH *74(H2 O) LINK C ZAE A 1 N ILE A 2 1555 1555 1.31 LINK C SER A 3 N HJV A 4 1555 1555 1.33 LINK C HJV A 4 N 28J A 5 1555 1555 1.33 LINK C 28J A 5 N ILE A 6 1555 1555 1.32 LINK C SER A 7 N DTH A 8 1555 1555 1.32 LINK C DTH A 8 N ALA A 9 1555 1555 1.32 LINK OG1 DTH A 8 C ILE A 11 1555 1555 1.32 LINK C ZAE B 1 N ILE B 2 1555 1555 1.33 LINK C SER B 3 N HJV B 4 1555 1555 1.32 LINK C HJV B 4 N 28J B 5 1555 1555 1.33 LINK C 28J B 5 N ILE B 6 1555 1555 1.33 LINK C SER B 7 N DTH B 8 1555 1555 1.34 LINK C DTH B 8 N ALA B 9 1555 1555 1.31 LINK OG1 DTH B 8 C ILE B 11 1555 1555 1.35 LINK C ZAE C 1 N ILE C 2 1555 1555 1.33 LINK C SER C 3 N HJV C 4 1555 1555 1.33 LINK C HJV C 4 N 28J C 5 1555 1555 1.33 LINK C 28J C 5 N ILE C 6 1555 1555 1.31 LINK C SER C 7 N DTH C 8 1555 1555 1.32 LINK C DTH C 8 N ALA C 9 1555 1555 1.33 LINK OG1 DTH C 8 C ILE C 11 1555 1555 1.29 LINK C ZAE D 1 N ILE D 2 1555 1555 1.32 LINK C SER D 3 N HJV D 4 1555 1555 1.33 LINK C HJV D 4 N 28J D 5 1555 1555 1.32 LINK C 28J D 5 N ILE D 6 1555 1555 1.32 LINK C SER D 7 N DTH D 8 1555 1555 1.33 LINK C DTH D 8 N ALA D 9 1555 1555 1.33 LINK OG1 DTH D 8 C ILE D 11 1555 1555 1.31 LINK C ZAE E 1 N ILE E 2 1555 1555 1.33 LINK C SER E 3 N HJV E 4 1555 1555 1.32 LINK C HJV E 4 N 28J E 5 1555 1555 1.32 LINK C 28J E 5 N ILE E 6 1555 1555 1.32 LINK C SER E 7 N DTH E 8 1555 1555 1.33 LINK C DTH E 8 N ALA E 9 1555 1555 1.32 LINK OG1 DTH E 8 C ILE E 11 1555 1555 1.28 LINK C ZAE F 1 N ILE F 2 1555 1555 1.32 LINK C SER F 3 N HJV F 4 1555 1555 1.33 LINK C HJV F 4 N 28J F 5 1555 1555 1.32 LINK C 28J F 5 N ILE F 6 1555 1555 1.32 LINK C SER F 7 N DTH F 8 1555 1555 1.32 LINK C DTH F 8 N ALA F 9 1555 1555 1.33 LINK OG1 DTH F 8 C ILE F 11 1555 1555 1.31 LINK C ZAE G 1 N ILE G 2 1555 1555 1.32 LINK C SER G 3 N HJV G 4 1555 1555 1.33 LINK C HJV G 4 N 28J G 5 1555 1555 1.32 LINK C 28J G 5 N ILE G 6 1555 1555 1.32 LINK C SER G 7 N DTH G 8 1555 1555 1.33 LINK C DTH G 8 N ALA G 9 1555 1555 1.33 LINK OG1 DTH G 8 C ILE G 11 1555 1555 1.25 LINK C ZAE H 1 N ILE H 2 1555 1555 1.32 LINK C SER H 3 N HJV H 4 1555 1555 1.31 LINK C HJV H 4 N 28J H 5 1555 1555 1.33 LINK C 28J H 5 N ILE H 6 1555 1555 1.33 LINK C SER H 7 N DTH H 8 1555 1555 1.33 LINK C DTH H 8 N ALA H 9 1555 1555 1.33 LINK OG1 DTH H 8 C ILE H 11 1555 1555 1.27 CRYST1 24.880 24.880 106.315 90.00 90.00 90.00 P 43 32 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.040193 0.000000 0.000000 0.00000 SCALE2 0.000000 0.040193 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009406 0.00000 HETATM 1 N ZAE A 1 24.041 39.993 47.670 1.00 15.94 N HETATM 2 CA ZAE A 1 22.701 39.482 47.891 1.00 12.87 C HETATM 3 C ZAE A 1 22.878 37.999 48.163 1.00 10.12 C HETATM 4 O ZAE A 1 23.756 37.624 48.941 1.00 14.31 O HETATM 5 CB ZAE A 1 22.081 40.175 49.098 1.00 10.38 C HETATM 6 CG ZAE A 1 20.627 39.826 49.299 1.00 17.67 C HETATM 7 CD1 ZAE A 1 20.209 39.204 50.456 1.00 19.25 C HETATM 8 CD2 ZAE A 1 19.741 40.124 48.299 1.00 21.13 C HETATM 9 CE1 ZAE A 1 18.863 38.896 50.584 1.00 24.03 C HETATM 10 CE2 ZAE A 1 18.407 39.825 48.434 1.00 23.09 C HETATM 11 CZ ZAE A 1 17.976 39.217 49.570 1.00 26.71 C HETATM 12 C10 ZAE A 1 24.643 39.581 46.410 1.00 14.42 C HETATM 13 H2 ZAE A 1 24.007 40.852 47.684 1.00 19.12 H HETATM 14 H ZAE A 1 24.544 39.716 48.311 1.00 19.12 H HETATM 15 HA ZAE A 1 22.116 39.640 47.134 1.00 15.44 H HETATM 16 HB2 ZAE A 1 22.156 41.134 48.978 1.00 12.46 H HETATM 17 HB3 ZAE A 1 22.574 39.917 49.892 1.00 12.46 H HETATM 18 HD1 ZAE A 1 20.813 38.997 51.132 1.00 23.10 H HETATM 19 HD2 ZAE A 1 20.045 40.532 47.521 1.00 25.35 H HETATM 20 HE1 ZAE A 1 18.555 38.472 51.353 1.00 28.83 H HETATM 21 HE2 ZAE A 1 17.807 40.036 47.756 1.00 27.70 H HETATM 22 HZ ZAE A 1 17.073 39.015 49.668 1.00 32.05 H HETATM 23 H11 ZAE A 1 24.914 40.367 45.909 1.00 17.31 H HETATM 24 H12 ZAE A 1 25.420 39.028 46.588 1.00 17.31 H HETATM 25 H13 ZAE A 1 23.997 39.075 45.893 1.00 17.31 H